Find out about our latest news and events.

News

Tuesday, 08 Aug 2017

Although significant advances in malaria control have been made in the past few decades, resistance to our current antimalarial drug repertoire threatens control efforts.

Read the article

Events

A group of eight diverse people smiling and sitting on steps at the Bio21 Institute.
22 Jul 2022 | 1pm

Mitochondrial diseases (MDs) are the largest and most common group of inherited metabolic disorders. They comprise over 350 monogenic diseases and affect at least one child born each week in Australia.

Read the article
7 Jul 2022 | 3pm

Nutritional deficiencies are a leading cause of human susceptibility to infectious diseases and antibiotic treatment failure. Specifically, our intake of dietary lipids has changed dramatically, yet microbe-lipid interactions during infection are poorly understood.

Read the article
22 Jun 2022 | 3 - 4pm

Bacterial infections remain a global public health challenge and there is a critical need for the identification and molecular understanding of new targets for antimicrobial design.

Read the article
9 Jun 2022 | 1pm

Current treatments for malaria are threatened by drug resistance, and new antimalarials are urgently required to ensure the continued ability to treat malaria infections into the future.

Read the article
A smiling woman in a white lab coat stands in a laboratory filled with shelves of chemical bottles and lab equipment.
2 Jun 2022 | 1:30pm

B0AT1 (Slc6a19) is a sodium-dependent neutral amino acid transporter catalyzing the secondary active transport of neutral amino acids across the brush border membrane of the kidney and intestine.

Read the article
A smiling woman with sunglasses on her head standing in front of a vibrant yellow rapeseed field under a clear blue sky.
2 Jun 2022 | 1pm

Malaria is an ancient disease leading to the death of more than half a million people every year.

Read the article